News & Updates

RYGB in severe obesity leads to weight loss, hypertension remission
RYGB in severe obesity leads to weight loss, hypertension remission
29 Aug 2022 byRoshini Claire Anthony

In patients with severe obesity, undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (RYGB) resulted in weight loss, according to long-term follow-up of the SLEEVEPASS* trial. However, remission of hypertension was more likely in patients who underwent RYGB compared with LSG.

RYGB in severe obesity leads to weight loss, hypertension remission
29 Aug 2022
Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
29 Aug 2022
Obese, postmenopausal women on proinflammatory diet at highest risk of breast cancer
Obese, postmenopausal women on proinflammatory diet at highest risk of breast cancer
29 Aug 2022
Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022

In the treatment of patients with severe COVID-19, adding the combination of pembrolizumab plus tocilizumab to standard of care (SOC) appears to result in higher and faster discharge from the hospital without sequelae, as shown in the proof-of-concept phase II COPERNICO trial.

Add-on pembrolizumab–tocilizumab combo reduces hospitalization period in severe COVID-19
29 Aug 2022
Daytime, nocturnal hypertension pose risk of kidney replacement therapy in kids with CKD
Daytime, nocturnal hypertension pose risk of kidney replacement therapy in kids with CKD
29 Aug 2022
HK data: Long-acting injectable antipsychotics safer, more effective than oral antipsychotics for schizophrenia
HK data: Long-acting injectable antipsychotics safer, more effective than oral antipsychotics for schizophrenia
29 Aug 2022 byKanas Chan

Long-acting injectable antipsychotics (LAIAs) for schizophrenia are associated with lower risks of disease relapse, hospitalizations, and suicide attempts vs oral antipsychotics (OAs), without an increased risk of adverse events (AEs), according to a 16-year population-based self-controlled case series (SCCS) study by the University of Hong Kong.

HK data: Long-acting injectable antipsychotics safer, more effective than oral antipsychotics for schizophrenia
29 Aug 2022
Gout, hyperuricaemia meds less common among diabetics on SGLT2is
Gout, hyperuricaemia meds less common among diabetics on SGLT2is
28 Aug 2022

Patients with type 2 diabetes mellitus (T2DM) taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) are less likely to be prescribed antigout or antihyperuricaemic drugs, a recent study has found.

Gout, hyperuricaemia meds less common among diabetics on SGLT2is
28 Aug 2022